Cargando…

COVID-19 Outcomes Among Users of CD20 Inhibitors for Immune-Mediated Diseases: A Comparative Cohort Study

OBJECTIVE: Patients with immune-mediated diseases treated with CD20 inhibitors may have worse COVID-19 outcomes due to impaired humoral immunity, but differences versus the general population are unknown. METHODS: We identified patients with immune-mediated diseases who received CD20 inhibitors with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Patel, Naomi J., D’Silva, Kristin M., Hsu, Tiffany Y-T., DiIorio, Michael, Fu, Xiaoqing, Cook, Claire, Prisco, Lauren, Martin, Lily, Vanni, Kathleen M.M., Zaccardelli, Alessandra, Zhang, Yuqing, Sparks, Jeffrey A., Wallace, Zachary S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366799/ https://www.ncbi.nlm.nih.gov/pubmed/34401883 http://dx.doi.org/10.1101/2021.08.05.21261643

Ejemplares similares

Coronavirus Disease 2019 Outcomes Among Recipients of Anti‐CD20 Monoclonal Antibodies for Immune‐Mediated Diseases: A Comparative Cohort Study
por: Patel, Naomi J., et al.
Publicado: (2021)

DMARD disruption, disease flare, and prolonged symptom duration after acute COVID-19 among participants with rheumatic disease: A prospective study
por: Di Iorio, Michael, et al.
Publicado: (2022)

DMARD disruption, rheumatic disease flare, and prolonged COVID-19 symptom duration after acute COVID-19 among patients with rheumatic disease: A prospective study
por: Di Iorio, Michael, et al.
Publicado: (2022)

Laboratory trends, hyperinflammation, and clinical outcomes for patients with a systemic rheumatic disease admitted to hospital for COVID-19: a retrospective, comparative cohort study
por: Hsu, Tiffany Y-T, et al.
Publicado: (2021)

Breakthrough infection after three doses of COVID-19 mRNA vaccine in systemic autoimmune rheumatic diseases: two cases in patients on TNF inhibitor monotherapy
por: Vanni, Kathleen MM, et al.
Publicado: (2022)

Incident systemic rheumatic disease following COVID-19
por: Hsu, Tiffany Y-T, et al.
Publicado: (2021)

Temporal trends in COVID-19 outcomes among patients with systemic autoimmune rheumatic diseases: From the first wave to Omicron
por: Kawano, Yumeko, et al.
Publicado: (2022)

Factors associated with COVID-19 breakthrough infection among vaccinated patients with rheumatic diseases: A cohort study
por: Patel, Naomi J., et al.
Publicado: (2023)

Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US ‘hot spot’
por: D’Silva, Kristin M, et al.
Publicado: (2020)

Acute and postacute COVID-19 outcomes for patients with rheumatoid arthritis: lessons learned and emerging directions 3 years into the pandemic
por: Zaccardelli, Alessandra, et al.
Publicado: (2023)

Outcomes with and without outpatient SARS-CoV-2 treatment for patients with COVID-19 and systemic autoimmune rheumatic diseases: A retrospective cohort study
por: Qian, Grace, et al.
Publicado: (2022)

COVID-19 and Disease-Modifying Anti-rheumatic Drugs
por: D’Silva, Kristin M., et al.
Publicado: (2021)

A Roadmap for Investigating Preclinical Autoimmunity Using Patient-Oriented and Epidemiologic Study Designs: Example of Rheumatoid Arthritis
por: Kowalski, Emily N., et al.
Publicado: (2022)

Immunomodulators and risk for breakthrough infection after third COVID-19 mRNA vaccine among patients with rheumatoid arthritis: A cohort study
por: Schiff, Abigail E., et al.
Publicado: (2023)

Outcomes with and without outpatient SARS-CoV-2 treatment for patients with COVID-19 and systemic autoimmune rheumatic diseases: a retrospective cohort study
por: Qian, Grace, et al.
Publicado: (2023)

Temporal trends in severe COVID-19 outcomes in patients with rheumatic disease: a cohort study
por: Jorge, April, et al.
Publicado: (2021)

Risk of severe COVID-19 outcomes associated with rheumatoid arthritis and phenotypic subgroups: a retrospective, comparative, multicentre cohort study
por: Figueroa-Parra, Gabriel, et al.
Publicado: (2022)

Impact of cross-coronavirus immunity in post-acute sequelae of COVID-19
por: Herman, Jonathan D., et al.
Publicado: (2022)

Novel Artificial Intelligence-Based Approaches for Ab Initio Structure Determination and Atomic Model Building for Cryo-Electron Microscopy
por: DiIorio, Megan C., et al.
Publicado: (2023)

Exploring the Structural Variability of Dynamic Biological Complexes by Single-Particle Cryo-Electron Microscopy
por: DiIorio, Megan C., et al.
Publicado: (2022)

Challenges and Opportunities of Targeted Behavioral Interventions for Groups at Risk for Developing Rheumatoid Arthritis
por: Zaccardelli, Alessandra, et al.
Publicado: (2021)

404. Impact of cross-coronavirus humoral immunity in post-acute sequelae of COVID-19 in systemic autoimmune rheumatic diseases patients
por: Herman, Jonathan, et al.
Publicado: (2023)

Validation of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis as the Cause of End‐Stage Renal Disease in the US Renal Data System
por: Cook, Claire E., et al.
Publicado: (2021)

Perceived Risk and Associated Shielding Behaviors in Patients With Rheumatoid Arthritis During the Coronavirus 2019 Pandemic
por: Cook, Claire, et al.
Publicado: (2021)

Derivation and Validation of Algorithms to Identify Patients With Immunoglobulin‐G4‐Related Disease Using Administrative Claims Data
por: Wallace, Zachary S., et al.
Publicado: (2022)

The Effects of Treatment on Body Mass Index in Giant Cell Arteritis: A Post Hoc Analysis of the GiACTA Trial
por: Patel, Naomi J., et al.
Publicado: (2021)

DENT-seq for genome-wide strand-specific identification of DNA single-strand break sites with single-nucleotide resolution
por: Elacqua, Joshua J., et al.
Publicado: (2021)

DELPHI Hipe system User's Manual (v. 2.20)
por: D\"onszelmann, M
Publicado: (1992)

CALICO User's Guide (Version 2.0)
por: Fischer, C, et al.
Publicado: (1997)

Environmentalstats for s-plus®: user’s manual for version 20
por: Millard, Steven P
Publicado: (2002)

Effectiveness of COVID-19 vaccination in immune-mediated inflammatory diseases
por: Sparks, Jeffrey A, et al.
Publicado: (2022)

Clinical Experience With a Multidisciplinary Model of Vascular Ultrasound for the Evaluation for Giant Cell Arteritis
por: Tedeschi, Sara K., et al.
Publicado: (2021)

The Effect of Achieving Serologic Remission on Subsequent Risk of Relapse, End-Stage Renal Disease, and Mortality in ANCA-Associated Vasculitis: A Target Trial Emulation Study
por: McDermott, Gregory C., et al.
Publicado: (2022)

Ill, Itinerant, and Insured: The Top 20 Users of Emergency Departments in Baltimore City
por: DiPietro, Barbara Y., et al.
Publicado: (2012)

Changing patterns of first e-cigarette flavor used and current flavors used by 20,836 adult frequent e-cigarette users in the USA
por: Russell, Christopher, et al.
Publicado: (2018)

Comparative effectiveness of BNT162b2 and ChAdOx1 nCoV-19 vaccines against COVID-19
por: Wei, Jie, et al.
Publicado: (2023)

AI in the hands of imperfect users
por: Kostick-Quenet, Kristin M., et al.
Publicado: (2022)

LIN-12/Notch Regulates GABA Signaling at the Caenorhabditis elegans Neuromuscular Junction
por: Sorkaç, Altar, et al.
Publicado: (2018)

Understanding Fibroblast Heterogeneity in Form and Function
por: Parker, Jennifer B., et al.
Publicado: (2023)

Risk of gout flares after COVID-19 vaccination: A case-crossover study
por: Li, Hui, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_v9eh84iu6dej72om85ki67pi72